Composition
Tamsulosin Hydrochloride Modified Release Tablets 0.4 mg
Description
URIARV 0.4 (Tamsulosin Hydrochloride Modified Release Tablets 0.4 mg) is an alpha-1 adrenergic blocker indicated for the treatment of benign prostatic hyperplasia (BPH) in adult men. It works by relaxing the smooth muscles of the prostate and bladder neck, helping improve urine flow and relieve symptoms such as difficulty in urination, frequent urination, weak urine stream, and incomplete bladder emptying. Manufactured under stringent quality standards, Arvantis Pharmaceuticals ensures safe, effective, and reliable modified-release tablets with consistent therapeutic performance. These tablets are ideal for PCD Pharma Franchise, third-party manufacturing, hospital supply, institutional procurement, and bulk distribution across Delhi and India.
Enter your details to start WhatsApp chat